[email protected]
We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. | × |
---|
Understand the COVID-19 Outbreak and its impact on global & regional businesses
request free proposal
Insights on a world turned upside down : Re-imagining
The post-COVID19 Business resilience & recovery
How effective strategies and business recovery plans are winning the race
request free proposal
Goldstein Market Intelligence help you navigate through the COVID-19 crisis,
we will provide you most relevant market insights on crisis management,
recovery strategy & business continuity.
2019-06-18
320
Global
Market Overview
The global cardiac pacemaker market is mainly driven owing to upsurge in cardiovascular diseases (CVD) majorly in developed and fast developing nations due to unhealthy diet, smoking, drug abuse, and excessive use of alcohol or caffeine, rise in geriatric population, worldwide. Further, given the trend towards a progressive ageing of populations, it is expected that the healthcare expenditure will continue to increase and will significantly aid the growth of cardiac pacemakers market. Through recent years, improvements in conventional technology and medical innovation have expanded the types and complexity of implantable devices to include such things as artificial hearts and deep-brain stimulators to control epilepsy. Further, the growing presence of chronic conditions, the number of patients who can benefit from implantable devices continues to grow. For instance, in United States heart disease is the leading cause of deaths. More than 600,000 Americans die of heart disease annually. That’s one in every four deaths in this country. Industry reports suggest that implantable device sales totaled about USD 43 billion in 2011 and are expected to grow to USD 74 billion in 2018. Such huge market for implantable devices shows the significant growth potential of cardiac pacemaker industry.
Goldstein Research analyst forecast global Cardiac Pacemaker market is likely to thrive with the emergence of new technologies and surge in digitalization of medical procedures and demand for analytic solutions. Further, the Cardiac Pacemaker market is expected to expand at a CAGR of 7.1% over the forecast period and the major growth regions are likely to be the Europe and North America.
By Product Type
Based on type of product type, implantable cardiac pacemaker dominated the market with a share of around 70.0% in 2016 and the segment is anticipated to witness lucrative growth during the forecast period.
By Technology Type
By Geography
Based on geography, North America is expected to dominate the market followed by Europe during the forecast period. Dominance of North America is majorly attributed to the advanced healthcare infrastructure and dominance in global healthcare IT industry. Moreover, US will maintain its dominance in North America over the forecast period. Further, Asia Pacific region and other developing nations are likely to emerge as the area with maximum growth potential owing to focus of key players in emerging economies and improving healthcare infrastructure.
The report covers the present ground scenario and the future growth prospects of the cardiac pacemakers for 2017-2025 along with the market players’ analysis. We calculated the market size and revenue share on the basis of revenue generated from major players in all major regions. Global cardiac pacemaker market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players.
Global Cardiac Pacemaker Market Outlook 2017-2025, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global cardiac pacemaker market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. “Global Cardiac Pacemaker Market Report” also recognizes value chain analysis to understand the cost differentiation, pricing models to provide competitive advantage to the existing and new entry players.
Our Global Cardiac Pacemaker Market Report comprises of the following companies as the key players: Abbott, BIOTRONIK, Boston Scientific, Medtronic, Cardiac Science, CCC Medical Devices, Cook Medical, GE Healthcare, MEDICO, SORIN GROUP, and ZOLL Medical Corporation
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
For a full detailed overview, send us the sample request.
Reasons to buy this market study
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements
OR Call Us:+1-646-568-7747Global Point of Care Testing (POCT) Devices Market Outlook 2024: Global Opportunity , Market Segmentation By Systems Basis, By Clinical Specialties & Diseases, By Areas of Use, By End User & by Region with Forecast 2017-2030
Global Home Healthcare Equipment Market Size , Share, By Device, By Distribution Channel, By End User & by Region with Forecast 2017-2030
Global Connected Healthcare Market Analysis by type, by function & by application with regional outlook and forecast to 2030
India In-Vitro Diagnostics (IVD) Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024
Global Connected Medical Device Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024